The Fascination With Neurostimulation
Tech entrepreneurs often get criticized for tackling frivolous problems in lieu of tough ones. Not so for neurotech. Startups are applying neurostimulation-based therapies (electrical or magnetic stimulation to the brain or nervous system, often through implantable devices) to treat paralysis, stroke, chronic pain, sensory loss, depression, and a long list of other serious ailments.
In addition to Neuronetics and Electcrocore, here are a few companies in this vein that stood out in our list:
Neuros Medical, which closed a $20 million Series A round in August, develops technology to deliver high-frequency stimulation to sensory nerves in the peripheral nervous system to block chronic pain.
Read More: https://news.crunchbase.com/news/vcs-back-neuro-startups-go-brain/?utm_source=cb_weekend&utm_medium=email&utm_campaign=20170930&utm_content=hero&utm_term=cta_inyourbrain
Via: WQAD 8
PHILADELPHIA – Each year, more than 300,000 people in the U.S. are diagnosed with carotid artery disease.
Office of the President Established to Lead Company during Medical Leave
Phase 1a Study Will Assess Novel Immuno-Oncology Therapeutic Candidate as a Single Agent in Solid Tumors
Via: WKOW 27
MADISON (WKOW) -- A new procedure at a Madison hospital is aiming to reduce the risks for people with cardiovascular problems.
CLEVELAND--(BUSINESS WIRE)--Neuros Medical, Inc., a neuromodulation company, announced today the appointment of Tom Wilder as President and CEO.
Hinge Health, a fledgling digital health startup that’s building hardware and software to tackle musculoskeletal (MSK) disorders, has raised $8 million in a Series A round of funding led by European VC giant Atomico, with participation from existing seed investors, including Eleven Two Capital and the Vertical Group.
Silk Road Medical said today it raised $47 million in a new funding round to support its Enroute products designed for transcarotid artery revascularization procedures.
Technology is offering a new fix for one of the most confounding health-care challenges: getting patients with chronic disease to take better care of themselves.
Via: Business Wire
SAN FRANCISCO & BLOOMFIELD, Conn.--(BUSINESS WIRE)--Building on the largest enrollment quarter in the company’s history, Omada Health today announced a $50 million fundraising round led by global health services leader Cigna (NYSE: CI). In addition to leading the fundraising round, Cigna will also grow its non-exclusive commercial partnership with Omada, adding the recognized Omada Program to Cigna’s suite of health improvement services. Joining the Cigna-led fundraising round were new investors Civilization Ventures and Sanofi Genzyme BioVentures.